Archive: June, 2016

 

 

Nexvet Presents Expanded Positive Clinical Data for Ranevetmab (NV-01) and Frunevetmab (NV-02) at ACVIM

DUBLIN, Ireland, June 09, 2016 (GLOBE NEWSWIRE)- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, is today presenting expanded results regarding completed clinical studies for ranevetmab (or “NV-01”) and frunevetmab...

Read more about Nexvet Presents Expanded Positive Clinical Data for Ranevetmab (NV-01) and Frunevetmab (NV-02) at ACVIM

Nexvet Announces Opening of Manufacturing Facility and Production Milestone Achievement

DUBLIN, Ireland, June 03, 2016 (GLOBE NEWSWIRE) - Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics developer, today announced the official opening of BioNua Limited, its veterinary biologics manufacturing facility in...

Read more about Nexvet Announces Opening of Manufacturing Facility and Production Milestone Achievement